bpc 157 chronic pancreatitis The Hidden Risks of BPC‑157: What Patients Need to Know About Contamination and Safety Stable Gastric Pentadecapeptide BPC 157

By month 4, GI side effects fade into background noise for 85%+ of patients, leaving appetite suppression as the primary ongoing effect, which is the desired therapeutic response

While not yet tested specifically in Lyme patients, studies demonstrate its influence on inflammatory pathways and immune cell signaling

You can, but more isn't necessarily better

Angiogenesis and Inflammation Reduction BPC 157 up-regulates vascular endothelial growth factor (VEGF), promoting angiogenesis around damaged tissues

The peptide complex is thought to possibly inhibit NF-B activation by affecting the phosphorylation of IB, a protein that inhibits NF-B